tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Davies, 40 are a HOLD (65.57%), 12 are a SELL (19.67%), 9 are a BUY (14.75%).
Analyst Robert Davies, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 35.42% that have a potential upside of 25.96% achieved within 239 days.
Robert Davies’s has documented 109 price targets and ratings displayed on 13 stocks. The coverage is on Healthcare, Energy, Financial Services, Consumer Cyclical, Communication Services, Basic Materials sectors.
Most recent stock forecast was given on PHG, Koninklijke Philips NV ADR at 08-May-2025.
Analyst best performing recommendations are on MED (MEDIFAST INC).
The best stock recommendation documented was for MED (MEDIFAST INC) at 10/18/2022. The price target of $108.77 was fulfilled within 1 day with a profit of $3.74 (3.32%) receiving and performance score of 33.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Dec-2021
$25.8
$2.37 (10.12%)
Hold Since 24-Feb-2021
$26
$2.76 (11.88%)
$30
What Year was the first public recommendation made by Robert Davies?
